期刊文献+

Meta分析中异质性方差区间估计方法及改进

The Estimating Methods and Improvement for Heterogeneity Variance in Meta Analysis
下载PDF
导出
摘要 Meta分析中的异质性程度可以用异质性方差度量。为了估计异质性方差,人们研究并给出了各种估计方法,如矩估计、最大似然估计、经验贝叶斯估计等。在点估计的基础上,还进一步研究了异质性方差的区间估计,从而更加准确和有效地度量异质性大小。构建置信区间的方法也有很多,如似然估计、WALD型置信区间、基于Q统计量的置信区间等。在介绍已有的几种异质性方差区间估计方法的基础上,给出了假设τ2近似服从正态分布的情况下,异质性方差的区间估计方法,导出了异质性方差置信区间的解析表达式。仿真计算及实例分析表明该方法是稳健、可靠的。 The heterogeneity in Meta analysis could be measured by variance. To estimate the heterogeneity va- riance, some methods such as moment estimation, maximum likelihood estimation, empirical Bayes estimation were given. On the basis of point estimation, the interval estimation of heterogeneity variance to measure the heterogenei- ty mote accurately and effectively is could researched. There are many methods for building the confidence intervals for heterogeneity variance, such as the likelihood estimation, WALD-type confidence intervals and Q-profile confi- dence intervals, etc. On the basis of introducing the estimation methods for heteroveneity variance, the heterogenei- ty variance subjects are assumed to the normal distribution approximately. Then the estimating method and analyti- cal expression for confidence intervals of heterogeneity variance are given. The simulation and case study demon- strate the new method is moderate and credible.
机构地区 西北工业大学
出处 《科学技术与工程》 北大核心 2012年第10期2251-2255,2259,共6页 Science Technology and Engineering
关键词 META分析 异质性方差 置信区间 正态分布 Meta-analysis heterogeneity variance confidence intervals normal distribution
  • 相关文献

参考文献2

二级参考文献21

  • 1Moher D, Pham B, Jones A, et al. Does quality of reports of randomized trials affect estimates of intervention efficacy reported in Meta-analysis[ J]. Lancet, 1998,352 : 609-613.
  • 2Nakagawa K, Tada H, Akashi A, et al. Randomised study of adjuvant chemotherapy for completely resected p-stage Ⅰ -ⅢA non- small cell lung cancer[J]. Br J Cancer, 2006, 95:817-821.
  • 3Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage Ⅰ BⅢ A non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ ANITA ] ) : a randomised controlled trial [ J ]. Lancet Oncol, 2006, 7 ( 9 ) :719 -727.
  • 4Munehisa I. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage Ⅰ non-small cell lung cancer [ J ]. Lung Cancer, 2005, 49:85-94.
  • 5Timothy W, Robert L, David J, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer[J]. N Engl J Med, 2005, 352(25) :2589-2597.
  • 6Jong HP, Lee CT, Lee HW, et al. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer[J]. Eur J Cardiothoracic Surg, 2005, 27:1086-1091.
  • 7Nakagawa M, Tanaka F, Tsubota N, et al. A randomized phase Ⅲ trial of adjuvant chemotherapy with UFT for completely resected pathological stage Ⅰ non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)-the 4th study [J]. Ann Oncol, 2005, 16(1) :75-80.
  • 8The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J]. N Engl J Med, 2004, 350(4) :351-360.
  • 9Waller D, Peake R J, Stephens D, et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial[ J ]. Eur J Cardiothorac Surg, 2004,26 : 173-182.
  • 10Koto H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung [J]. N Engl J Med, 2004, 350(17) :1713-1721.

共引文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部